Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised Harold G. Hamm on the deal. Harold G. Hamm announced his entry into definitive agreements with Continental Resources, Inc. (“Continental”) pursuant to which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised The Coterie on the deal. The Coterie, a developer of lending and investment platform for founders, raised $40 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Winstead PC advised Hawaiian Airlines on the deal. Hawaiian Holdings, Inc., the parent company of Hawaiian Airlines, Inc., announced an agreement with Amazon.com,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Merge on the deal. Merge, a Unified API for B2B integrations, announced the close of a $55 million Series B...
You must be a Standard 1 Year member to access this content.
White & Case and Osler, Hoskin & Harcourt LLP advised Inversago Pharma Inc. on the deal, while Wilson Sonsini advised NEA. Inversago Pharma Inc., a clinical-stage...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised DICE Therapeutics on the deal. DICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Zymeworks on the deal. Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Ltd. announced that they entered into an exclusive license agreement to develop...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini represented YS Biopharma on the deal. YishengBio Co., Ltd (YS Biopharma), a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics, and Summit...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Enable on the deal. Enable, a SaaS platform that helps B2B companies manage their incentive and rebate programs, announced it...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Stability AI on the transaction. Stability AI, one of the world’s first community-driven, open-source artificial intelligence (AI) company announced $101...
You must be a Standard 1 Year member to access this content.
